776
Participants
Start Date
November 16, 2018
Primary Completion Date
September 25, 2025
Study Completion Date
September 25, 2028
FOLFOXIRI
Irinotecan165 mg/m2、Oxaliplatin85 mg/m2、Left-calcium leucovorin 200mg/㎡,Intravenous infusion,first day. Then, 5-FU 1600 mg/m2/d×2 continuous intravenous infusion(total 3200 mg/m2,infusion 46 hours)in the next two days. Repeat every 14 days.
XELOX
XELOX consisting of 130 mg/m2 oxaliplatin administered intravenously on day 1 and 1,000 mg/m2 capecitabine administered orally twice daily on days 1-14 for a 3-week cycle.
Chemoradiotherapy
"Chemotherapy: oral capecitabine(1650 mg/m2)twice daily during radiotherapy without weekend breaks.~Radiation: Radiation therapy is administered via intensity-modulated radiation therapy (IMRT) with a linear accelerator, 6MV-X ray. The patients are scheduled to receive a GTV expanding 6mm to form PTV1 and CTV expanding 6mm to form PTV2. The dose of PTV1 is 50Gy/25 times for 35 days and the dose of PTV2 is 45Gy/25 times for 35 days. Patients were treated in consecutive days per week for a total of 5 weeks."
TME operation
TME operation
efficacy evaluation
chest/ abdominal CT、pelvic nuclear magnetic resonanceimaging、transrectal ultrasonography
RECRUITING
Cancer center of Sun Yat-sen University, Guangzhou
NOT_YET_RECRUITING
Medical Oncology,Sun Yat-sen University Cancer Center, Guangzhou
Sun Yat-sen University
OTHER